Dr. Rebecca Harrison, MD
Claim this profileBC Cancer - The Vancouver Center
Studies Brain Tumor
Studies Nervous System Tumors
6 reported clinical trials
13 drugs studied
Area of expertise
1Brain Tumor
IDH positive
1p/19q co-deletion positive
H3 K27M positive
2Nervous System Tumors
IDH positive
1p/19q co-deletion positive
1p/19q loss positive
Affiliated Hospitals
Clinical Trials Rebecca Harrison, MD is currently running
ONC201
for Brain Tumor
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Recruiting1 award Phase 3
Radiation and Temozolomide vs. PCV Chemotherapy
for Brain Tumor
Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether giving radiation with concomitant and adjuvant temozolomide versus radiation with adjuvant PCV is more effective in treating anaplastic glioma or low grade glioma.
Recruiting2 awards Phase 38 criteria
More about Rebecca Harrison, MD
Clinical Trial Related6 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Rebecca Harrison, MD has experience with
- ONC201
- Survey Administration
- Selinexor
- Temozolomide (TMZ)
- TTField
- Carmustine
Breakdown of trials Rebecca Harrison, MD has run
Brain Tumor
Nervous System Tumors
Mesial Temporal Sclerosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rebecca Harrison, MD specialize in?
Rebecca Harrison, MD focuses on Brain Tumor and Nervous System Tumors. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are 1p/19q co-deletion positive.
Is Rebecca Harrison, MD currently recruiting for clinical trials?
Yes, Rebecca Harrison, MD is currently recruiting for 2 clinical trials in Vancouver British Columbia. If you're interested in participating, you should apply.
Are there any treatments that Rebecca Harrison, MD has studied deeply?
Yes, Rebecca Harrison, MD has studied treatments such as ONC201, Survey Administration, Selinexor.
What is the best way to schedule an appointment with Rebecca Harrison, MD?
Apply for one of the trials that Rebecca Harrison, MD is conducting.
What is the office address of Rebecca Harrison, MD?
The office of Rebecca Harrison, MD is located at: BC Cancer - The Vancouver Center, Vancouver, British Columbia V5Z 4E6 Canada. This is the address for their practice at the BC Cancer - The Vancouver Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.